| Gifts from Drug Companies to Doctors Influence the Doctors - NO KIDDING! |
|
|
|
| Written by George |
| Tuesday, 19 May 2009 17:00 |
|
The New York Times reported that small gifts from drug manufacturers can positively influence doctors. The suggestion of course is that the making of small gifts can influence how doctors go about practicing medicine and in particular their prescription patterns. A study titled "Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences" was recently published in the Archives of Internal Medicine and the conclusion in the abstract states:
So the question becomes whether this is good or bad practice - ethical or unethical. Should drug companies be allowed to attempt to influence the prescription practices at all? Is it good business or bad? These are tough questions.
Drug companies make money based on the drugs they sell. They complain that millions of dollars are spent on research and development for drugs that will never be commercially viable and when a drug is developed that is commercially viable they need to reap the benefit (profit) to fill their coffers for more research and development. The never-ending circle of profit - research and development - selling all go hand in hand. The drug companies are competitive with each other at least to a point and they need to market their product just like anyone else. Should they be restricted to not giving gifts that influence the prescription practices of doctors? This question infers that doctors, because they have been given repeated small gifts, may prescribe to you one drug versus another because they feel soem empathy toward the drug company from which they received gifts. That has far-reaching consequences and infers that the drug prescribed may not be as good for the patient versus some other drug. This study does not say that. Often we hear of educational institutions being awarded money grants by private companies to R&D their drugs - does that have an undue influence? In my opinion the answer is obviously yes. Should this private company funding be allowed - what are the alternatives - would the government need to spend more in R&D - tough questions for sure. I do not have the answers - all I know is that when a doctor sits in front of me with a clip board that has drug X named on it and he proceeds to prescribe drug X to me I wonder - is that the right drug for me or is the doctor prescribing it because the drug manufacturer of drug X bought my doctor lunch. This is a challenging area of ethics and one that the medical community has been unable to cope with internally. I would think that the American Medical Association or other like bodies, either nationally or state leverl, would address this issue. Maybe the money is too good.
Bookmark
Email This
Hits: 277 Comments (0)
![]() Write comment
|
| Last Updated ( Saturday, 23 May 2009 10:05 ) |